Javier A Bustos Selected Research

Antiparasitic Agents (Antiparasitics)

1/2022	Porcine model of neurocysticercosis by intracarotid injection of Taenia solium oncospheres: Dose assessment, infection outcomes and serological responses.
11/2021	Frequency and Determinant Factors for Calcification in Neurocysticercosis.
10/2020	Brain calcification because of neurocysticercosis: a vast field to be explored.
11/2019	Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.
6/2017	Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.
1/2016	Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.
12/2015	Successful Antiparasitic Treatment for Cysticercosis is Associated with a Fast and Marked Reduction of Circulating Antigen Levels in a Naturally Infected Pig Model.
3/2015	Combined antiparasitic treatment for neurocysticercosis - Authors' reply.
9/2014	Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after.
8/2014	Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Javier A Bustos Research Topics

Disease

16	Neurocysticercosis 01/2022 - 01/2005
15	Cysts 01/2022 - 02/2006
8	Cysticercosis 04/2021 - 09/2005
6	Infections 01/2022 - 02/2007
5	Seizures (Absence Seizure) 11/2021 - 09/2014
3	Inflammation (Inflammations) 05/2018 - 01/2016
2	Epilepsy (Aura) 01/2020 - 01/2016
2	Taeniasis 04/2012 - 09/2005
1	Communicable Diseases (Infectious Diseases) 05/2022
1	Neoplasms (Cancer) 05/2022
1	Central Nervous System Cysts (Suprasellar Cyst) 01/2022
1	Immune Reconstitution Inflammatory Syndrome 10/2021
1	Flushing 12/2020
1	Temporal Lobe Epilepsy 01/2020
1	Echinococcosis (Hydatid Cysts) 07/2011
1	Tuberculosis (Tuberculoses) 01/2005
1	Tuberculoma 01/2005

Drug/Important Bio-Agent (IBA)

12	Antiparasitic Agents (Antiparasitics)IBA 01/2022 - 07/2011
8	Albendazole (Albenza)FDA Link 11/2021 - 02/2006
6	Praziquantel (Biltricide)FDA Link 11/2019 - 07/2011
4	AntigensIBA 01/2022 - 12/2015
4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 08/2014
4	AntibodiesIBA 09/2020 - 09/2005
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2020
2	EnzymesIBA 01/2022 - 01/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 09/2014
2	oxfendazoleIBA 04/2021 - 08/2012
2	GadoliniumIBA 06/2017 - 01/2016
2	AnthelminticsIBA 06/2017 - 01/2016
2	nitazoxanide (NTZ)FDA Link 08/2012 - 02/2007
1	ImmunosorbentsIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 09/2020
1	Immunoglobulin M (IgM)IBA 09/2020
1	albendazole sulfoxideIBA 11/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	lentil lectinIBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	brain synaptic membrane glycoprotein gp 50 (GP50)IBA 01/2018
1	Evans Blue (Blue, Evans)FDA Link 01/2016
1	Contrast MediaIBA 01/2016
1	Capsules (Microcapsules)IBA 01/2016
1	SteroidsIBA 09/2014
1	Prednisone (Sone)FDA LinkGeneric 08/2012
1	Indicators and Reagents (Reagents)IBA 04/2012
1	Choline (Choline Chloride)IBA 01/2005
1	LipidsIBA 01/2005
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2005
1	Protons (Proton)IBA 01/2005
1	CreatineIBA 01/2005

Therapy/Procedure

7	Therapeutics 10/2021 - 08/2014
3	Aftercare (After-Treatment) 11/2021 - 05/2018
1	Retreatment 11/2021
1	Bathroom Equipment 12/2020